Medim Science Raises Funds for Macrophage-Targeting Biologics in Cancer Therapy
Hangzhou-based Medim Science, China’s first pharma firm focused on macrophage-targeting biologics, has reportedly raised tens...
Deals
Tibet Duo Rui and Nanjing Heron Forge Pharmaceutical Collaboration in China
China-based Tibet Duo Rui Pharmaceutical Co., Ltd and Nanjing Heron Pharmaceutical Science and Technology Co.,...
MegaRobo and Danaher Life Sciences Partner on Lab Automation in China
Beijing-based MegaRobo Technologies, a robotics and AI firm in life sciences, has partnered with Danaher...
U Protech Secures Angel Financing for PROTAC and Molecular Glue Drug Pipeline
U Protech, a Hangzhou-based biotech focused on next-generation protein degradation therapies, has raised tens of...
J&J China, Tencent Launch Digital Rhinitis Platform “Love Nose e-Station”
Johnson & Johnson’s (J&J, NYSE: JNJ) J&J China Self Care and China’s Tencent have launched...
Neukio Biotherapeutics Completes USD 50M Series A-1 Financing for iPSC-CAR-NK Therapy
Shanghai-based Neukio Biotherapeutics, a developer of iPSC-derived chimeric antigen receptor natural killer (CAR-NK) cell therapies,...
Acorda Therapeutics Licenses Preclinical Drug Nepicastat to China’s Asieris
US-based Acorda Therapeutics Inc. (Nasdaq: ACOR) announced a licensing agreement with China’s Asieris Pharmaceuticals for...
Novartis Partners with Beijing’s Changping District to Expand Drug Development
Swiss pharma giant Novartis (NYSE: NVS) has partnered with Beijing’s Changping district government to expand...
Mayo Clinic Launches Mayflower BioVentures to Accelerate Cell and Gene Therapies
The Mayo Clinic, a leading US hospital group, has launched Mayflower BioVentures, a cell and...
Biointron Raises USD 72M in Series B to Expand CRO Services and Antibody Platform
Shanghai-based Biointron, a recombinant protein/antibody reagent contract research organization (CRO), has raised nearly RMB 500...
RoosterBio Taps MBL Beijing Biotech as Exclusive Distributor in China
US-based RoosterBio Inc. has appointed MBL Beijing Biotech, a subsidiary of JSR Life Sciences Company,...
E-nitiate Biopharma Raises RMB 100M in Series A to Advance Autoimmune Disease Drugs
China-based E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd, a drug developer focused on autoimmune diseases, has raised...
Kangtai Bio Partners with Philippine Firm on Pneumonia Vaccines
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has partnered with an unnamed Philippine enterprise...
Onekdrug Raises Series B+ Funding to Boost Pharmaceutical B2B Services
Hunan Wholesale Pharmaceutical Technology Co., Ltd, operating as Onekdrug, has raised tens of millions of...
Fosun Pharma to Invest RMB 1B in Chengdu Vaccine Base
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) announced that its subsidiaries, Shanghai Fosun Pharmaceutical...
Luca Healthcare Raises Pre-Series A Funding for Digital Biomarker R&D
Shanghai-based Luca Healthcare Co., Ltd, a firm specializing in digital biomarkers and therapeutics, has raised...
InnoCare Pharma Files for STAR Market IPO to Raise RMB 4B for Drug R&D
China-based InnoCare Pharma (HKG: 9969) has filed for an initial public offering (IPO) on the...
J&J MedTech Joins China’s Surgical Training Program to Skill Up Surgeons
The National Institute of Hospital Administration (NIHA) and the National Health Commission (NHC) launched the...
Acchrom Tech Raises USD 14.45M in Angel Round Led by BioTrack Capital to Expand Chromatography Solutions
Beijing-based chromatography specialist Acchrom Tech has raised RMB 100 million (USD 14.45 million) in an...
Shanghai Bao Pharma Raises USD 100M in Series B to Advance Drug Delivery Tech
Shanghai Bao Pharmaceuticals Co., Ltd has raised over USD 100 million in a Series B...